2/12
07:46 am
mrkr
Marker Therapeutics, Inc. (NASDAQ: MRKR) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Low
Report
Marker Therapeutics, Inc. (NASDAQ: MRKR) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
12/19
08:15 am
mrkr
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma [Yahoo! Finance]
Medium
Report
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma [Yahoo! Finance]
12/19
08:11 am
mrkr
Marker Therapeutics Announces $16.1 Million Private Placement [Yahoo! Finance]
Medium
Report
Marker Therapeutics Announces $16.1 Million Private Placement [Yahoo! Finance]
12/19
08:06 am
mrkr
Marker Therapeutics Announces $16.1 Million Private Placement
Medium
Report
Marker Therapeutics Announces $16.1 Million Private Placement
12/19
08:05 am
mrkr
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
Medium
Report
Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma
12/17
07:32 am
mrkr
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer [Yahoo! Finance]
Medium
Report
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer [Yahoo! Finance]
12/17
07:00 am
mrkr
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
Low
Report
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
12/10
08:30 am
mrkr
Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium
Low
Report
Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium
12/6
08:30 am
mrkr
Marker Therapeutics Leads 3 Noteworthy US Penny Stocks [Yahoo! Finance]
Low
Report
Marker Therapeutics Leads 3 Noteworthy US Penny Stocks [Yahoo! Finance]
11/26
11:09 am
mrkr
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit [Yahoo! Finance]
Low
Report
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit [Yahoo! Finance]
11/26
11:00 am
mrkr
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit
Low
Report
Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit